Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05244096
NCT05244096Active, not recruitingNot Applicable

A Retrospective Chart Review Study to Determine the Effects of Psychotropic Medications and Prior Psychiatric Diagnoses on COVID-19 Patients' Disease Progression, and Severity.

Northwestern University1 site in 1 country65,000 target enrollmentStarted: January 12, 2022Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
65,000
Locations
1
Primary Endpoint
Hazard Ratio
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

A retrospective chart review study to determine the effects of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression, and severity.

Detailed Description

The goal of this study would be to study the association between use of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression and severity.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Individuals with a positive COVID-19 test between March 15 2020 to November 30 2021 at Northwestern Medicine hospitals.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Hazard Ratio

Time Frame: March 15 2020 to Nov 30 2021

HR of using psych drugs or having psych diagnosis

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jeffrey Rado

Associate Professor

Northwestern University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic PatientsSchizophrenia Spectrum and Other Psychotic DisordersPeriodontal Diseases
NCT06040944Fayoum University64
Completed
Not Applicable
A Study Based on the French National Health Insurance Database in Participants With Psychotic DisordersPsychotic Disorders
NCT05633108Eisai Co., Ltd.579,728
Unknown
Not Applicable
Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and NeuroimagingDepressive Disorder
NCT01831440Nanjing Medical University200
Recruiting
Unknown
A study on the effects of pharmacotherapy and psychosocial treatment of somatic symptom disorders in the orofacial region (e.g. burning mouth syndrome, temporomandibular disorder, and persistent idiopathic facial pain) using personality tendencies, nurturing experiences, and support from others as indicators.somatic symptom disorders in the orofacial region
JPRN-UMIN000050995Department of Oral and Maxillofacial Surgery, School of Dentistry, Aichi Gakuin University500
Active, not recruiting
Not Applicable
Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective StudyPsychotic Disorders
NCT05872555Mark Weiser, MD, Principal Investigator22,777